Literature DB >> 14241920

'B 663' POSSIBLE ANTI-INFLAMMATORY ACTION IN LEPROMATOUS LEPROSY.

S G BROWNE.   

Abstract

Keywords:  ANTI-INFLAMMATORY AGENTS; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY; ERYTHEMA NODOSUM; LEPROSY; PHENAZINES; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1965        PMID： 14241920     DOI： 10.5935/0305-7518.19650003

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  4 in total

1.  Corneal changes in patients treated with clofazimine.

Authors:  P E Wålinder; L Gip; M Stempa
Journal:  Br J Ophthalmol       Date:  1976-07       Impact factor: 4.638

2.  Apoptosis-inducing activity of clofazimine in macrophages.

Authors:  Yasuo Fukutomi; Yumi Maeda; Masahiko Makino
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

3.  Identification of crystals of the rimino-phenazine compound B663 (Lamprene: clofazimine) in mouse spleen macrophages by thin layer chromatography and mass spectrum analysis.

Authors:  R T Aplin; A C McDougall
Journal:  Experientia       Date:  1975-04-15

Review 4.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.